Factor XIIIa cross-linking of the Marburg fibrin: Formation of α(m) · γ(n)-Heteromultimers and the α-chain-linked albumin·γ complex, and disturbed protofibril assembly resulting in acquisition of plasmin resistance relevant to thrombophila

Blood

Volumn 91, Issue 9, 1998, Pages 3282-3288

  Sugo, Teruko ^a   Nakamikawa, Chizuko ^b   Takebe, Mikihiro ^b   Kohno, Lsao ^b   Egbring, Rudorf ^b   Matsuda, Michio ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8A; FIBRIN; PLASMIN;

ALPHA CHAIN; ARTICLE; COMPLEX FORMATION; CROSS LINKING; DISULFIDE BOND; HUMAN; HUMAN CELL; MARBURG VIRUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SOLUBILIZATION; STOP CODON; THROMBOPHILIA;

EID: 0032080090     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3282.3282_3282_3288     Document Type: Article

References (29)

1. Koopman J, Haverkate F, Grimbergen J, Engesser L, Navakova I, Kerst AFJA, Load ST: Abnormal fibrinogens IJmuiden (BβArg14→Cys) and Nijmegen (BβArg44→Cys) form disulfide-linked fibrinogen albumin complexes. Proc Natl Acad Sci USA 89:3478, 1992
2. Koopman J, Haverkate F, Grimbergen J, Load ST, Mosesson MW, DiOrio JP, Siebenlist KS, Legrand C, Soria J, Soria C, Caen JP: Molecular basis for fibrinogen Dusart (Aα554 Arg→Cys) and its association with abnormal fibrin polymerization and thrombophila. J Clin Invest 91:1637, 1993
3. Wada Y, Load ST: A correlation between thrombotic disease and a specific fibrinogen abnormality (Aα 554 Arg→Cys) in two unrelated kindred, Dusart and Chapel Hill III. Blood 84: 3709, 1994
4. Kamura T, Tsuda H, Yae Y, Hattori S, Ohga S, Shibata Y, Kawabata S, Hamasaki N: An abnormal fibrinogen Fukuoka II (Gly-Bβl5→Cys). Characterized by fibrin lateral association and mixed disulfide formation. J Biol Chem 270:29392, 1995
5. Terukina S, Matsuda M, Hirata H, Takeda Y, Miyata T, Takano T, Shimonishi Y: Substitution of γ Arg-275 by Cys in an abnormal fibrinogen, "Fibrinogen Osaka II." J Biol Chem 263:13579, 1988
6. Mosesson MW, DiOrio JP, Shainoff JR, Siebenlist KR, Amrani DL, Homandberg GA, Soria J, Soria C, Samama M: Studies on the ultrastructure of fibrin lacking fibrinopeptide B (b-fibrin). Blood 69:1073, 1987
7. Miyata T, Terukina S, Matsuda M, Kasamatsu M, Takeda Y, Murakami T, Iwanaga S: An amino acid substitution of Aα arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two Aα-chains. J Biochem 102:93, 1987
8. Koopman JK, Haverkate F, Grimbergen J, Egbring R, Lord ST: Fibrinogen Marburg: A homozygous case of dysfibrinogenemia, lacking amino acids Aα 461-610 (Lys 461 AAA → stop TAA). Blood 80:1972, 1992
9. Fuchs G, Egbring R, Havemann K: Fibrinogen Marburg, a new genetic variant of fibrinogen. Blut 34:107, 1977
10. Takebe M, Soe G, Kohno I, Sugo T, Matsuda M: Calcium ion-dependent monoclonal antibody against human fibrinogen: Preparation, characterization, and application to fibrinogen purification. Thromb Haemost 73:662, 1995
11. Tanabe S, Sugo T, Matsuda M: Synthesis of protein C in human umbilical vein endothelial cells. J Biochem 109:924, 1991
12. Lorand L, Credo RB, Janus TJ: Factor XIII (Fibrin-stabilizing factor). Methods Enzymol 80: 333, 1981
13. Lorand L, Urayama T, Kiewiet JWC, Nossel HL: Diagnostic and Genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest 48:1054, 1969
14. Veklich YI, Gorkun OV, Medved' LV, Nieuwenhuizen W, Weisel JW: Carboxy-terminal portion of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated αC fragments on polymerization. J Biol Chem 268:13577, 1993
15. Kudryk BJ, Collen D, Woods KR, Blombäck B: Evidence for localization of polymerization sites in fibrinogen. J Biol Chem 249: 3322, 1974
16. Olexa S, Budzynsky AZ: Evidence for four different polymerization sites involved in human fibrinogen. Proc Natl Acad Sci USA 77:1374, 1980
17. Laudano AP, Doolittle RF: Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 19:1013, 1980
18. Corcoran DH, Ferguson EW, Fretto LJ, McKee PA: Localization of a cross-link donor site in the α-chain of human fibrinogen. Thromb Res 19:883, 1980
19. Sakata Y, Aoki, N: Cross-linking of α2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 65:290, 1980
20. 2 plasmin inhibitor. J Biol Chem 261: 15591, 1986
21. Sobel JH, Trakht I, Wu HQ, Rudchenko S, Egbring R: α-chain cross-linking in fibrin(ogen) Marburg. Blood 86:989, 1995
22. Gabriel DA, Muga K, Boothroyd EM: The effect of fibrin structure on fibrinolysis. J Biol Chem 267:24259, 1992
23. Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS, Soria J, Soria C, Caen JP: The relationship between the fibrinogen D domain self-association/cross-linking site (γXL) and the fibrinogen Dusart abnormality (AαR554C-albumin). J Clin Invest 97:2342, 1996
24. Woodhead JL, Nagaswami C, Matsuda M, Arocha-Piñango CL, Weisel JW: The ultrastructure of fibrinogen Caracas II molecule, fibers, and clots. J Biol Chem 271:4946, 1996
25. Collet JP, Woodhead JL, Soria J, Soria C, Mirshahi M, Caen JP, Weisel JW: Fibrinogen Dusart: Electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. Biophys J 70:500, 1996
26. Maekawa H, Yamazumi K, Muramatsu S, Kaneko M, Hirata H, Takahashi N, de Bosch NB, Carvajal Z, Ojeda A, Arocha-Piñango, Matsuda M: An Aα Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. J Biol Chem 266:11575, 1991
27. Arocha-Piñango CL, de Bosh NB, Torres A, Caires-Tronchoni D, Marci R, Vidai H, Rizzo GM: Dysfibrinogenemias in Latin America. A cooperative study group. Rev Iberoamer Thromb Hemostasia 3:110, 1990
28. Soria C, Soria J, Caen P: A new type of congenital dysfibrinogenemea with defective fibrin lysis-Dusart syndrome: Possible relation to thrombosis. Br J Haematol 53:575, 1983
29. Carrell N, Gabriel DA, Blatt PM, Carr ME, McDonagh J: Hereditary dysfibrinogenemea in a patient with thrombotic diseases. Blood 62:439, 1983